Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

[Position statement of the Spanish Association of Paediatrics-Spanish Society of Paediatric Infectious Diseases (AEP-SEIP) on the treatment of multidrug-resistant bacterial infections].

Aguilera-Alonso D, Escosa-García L, Goycochea-Valdivia WA, Soler-Palacín P, Saavedra-Lozano J, Rodrigo C, Cercenado E, Ramos JT, Baquero-Artigao F.

An Pediatr (Barc). 2019 Nov;91(5):351.e1-351.e13. doi: 10.1016/j.anpedi.2019.08.002. Epub 2019 Oct 19. Spanish.

2.

Highlights at the ASM Microbe 2018, Atlanta (USA).

Cercenado E.

Rev Esp Quimioter. 2019 Sep;32 Suppl 2:10-15. Review. No abstract available.

3.

Increase of serotype 8, ST53 clone, as the prevalent strain of Streptococcus pneumoniae causing invasive disease in Madrid, Spain (2012-2015).

Sanz JC, Rodríguez-Avial I, Ríos E, García-Comas L, Ordobás M, Cercenado E.

Enferm Infecc Microbiol Clin. 2019 Jun 25. pii: S0213-005X(19)30188-0. doi: 10.1016/j.eimc.2019.05.006. [Epub ahead of print] English, Spanish.

PMID:
31253424
4.

Direct identification of pneumococcal serotypes in blood cultures by a PCR-reverse-hybridisation technique.

Sanz JC, de Luis R, Del Río S, Gamen S, Cercenado E, Orellana MA, Yuste J.

Enferm Infecc Microbiol Clin. 2019 Jun 24. pii: S0213-005X(19)30183-1. doi: 10.1016/j.eimc.2019.04.010. [Epub ahead of print] English, Spanish.

PMID:
31248724
5.

Evaluation of the Alfred AST® system for rapid antimicrobial susceptibility testing directly from positive blood cultures.

Sánchez-Carrillo C, Pescador P, Ricote R, Fuentes J, Losada C, Candela A, Cercenado E.

Eur J Clin Microbiol Infect Dis. 2019 Sep;38(9):1665-1670. doi: 10.1007/s10096-019-03595-y. Epub 2019 May 22.

PMID:
31119576
6.

Epidemiology of MRSA CC398 in hospitals located in Spanish regions with different pig-farming densities: a multicentre study.

Ceballos S, Aspiroz C, Ruiz-Ripa L, Reynaga E, Azcona-Gutiérrez JM, Rezusta A, Seral C, Antoñanzas F, Torres L, López C, López-Cerero L, Cercenado E, Zarazaga M, Torres C; Study Group of clinical LA-MRSA .

J Antimicrob Chemother. 2019 Aug 1;74(8):2157-2161. doi: 10.1093/jac/dkz180.

PMID:
31098612
7.

Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems.

Cantón R, Oliver A, Alós JI, de Benito N, Bou G, Campos J, Calvo J, Canut A, Castillo J, Cercenado E, Domínguez MÁ, Fernández-Cuenca F, Guinea J, Larrosa N, Liñares J, López-Cerero L, López-Navas A, Marco F, Mirelis B, Moreno-Romo MÁ, Morosini MI, Navarro F, Oteo J, Pascual Á, Pérez-Trallero E, Pérez-Vázquez M, Soriano A, Torres C, Vila J, Martínez-Martínez L.

Enferm Infecc Microbiol Clin. 2019 Mar 13. pii: S0213-005X(19)30135-1. doi: 10.1016/j.eimc.2019.01.017. [Epub ahead of print] Review. English, Spanish.

PMID:
30878313
8.

Activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacterales isolates recovered from intensive care unit patients in Spain: The SUPERIOR multicentre study.

García-Fernández S, García-Castillo M, Bou G, Calvo J, Cercenado E, Delgado M, Pitart C, Mulet X, Tormo N, Mendoza DL, Díaz-Regañón J, Cantón R; SUPERIOR Study Group.

Int J Antimicrob Agents. 2019 May;53(5):682-688. doi: 10.1016/j.ijantimicag.2019.02.004. Epub 2019 Feb 12.

PMID:
30769199
9.

Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017).

Cantón R, Loza E, Aznar J, Castillo FJ, Cercenado E, Fraile-Ribot PA, González-Romo F, López-Hontangas JL, Rodríguez-Lozano J, Suárez-Barrenechea AI, Tubau F, Díaz-Regañón J, López-Mendoza D; SMART-Spain Working Group.

Rev Esp Quimioter. 2019 Apr;32(2):145-155. Epub 2019 Feb 13.

10.

Review of the impact of MALDI-TOF MS in public health and hospital hygiene, 2018.

Rodríguez-Sánchez B, Cercenado E, Coste AT, Greub G.

Euro Surveill. 2019 Jan;24(4). doi: 10.2807/1560-7917.ES.2019.24.4.1800193.

11.

A Case-Control Study of Real-Life Experience with Ceftolozane-Tazobactam in Patients with Hematologic Malignancy and Pseudomonas aeruginosa Infection.

Fernández-Cruz A, Alba N, Semiglia-Chong MA, Padilla B, Rodríguez-Macías G, Kwon M, Cercenado E, Chamorro-de-Vega E, Machado M, Pérez-Lago L, García de Viedma D, Díez Martín JL, Muñoz P.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e02340-18. doi: 10.1128/AAC.02340-18. Print 2019 Feb.

12.

Serotypes and genotypes of S. pneumoniae isolates from adult invasive disease in Spain: A 5-year prospective surveillance after pediatric PCV13 licensure. The ODIN study.

Fenoll A, Ardanuy C, Liñares J, Cercenado E, Marco F, Fleites A, Rodríguez-Mayo M, López-Hontangas JL, Palop B, Aller AI, Buendía B, Méndez C, Cifuentes I; ODIN Study Group.

Vaccine. 2018 Dec 18;36(52):7993-8000. doi: 10.1016/j.vaccine.2018.10.098. Epub 2018 Nov 16.

PMID:
30449634
13.

From CLSI to EUCAST, a necessary step in Spanish laboratories.

Larrosa MN, Benito N, Cantón R, Canut A, Cercenado E, Fernández-Cuenca F, Guinea J, López-Navas A, Moreno MÁ, Oliver A, Martínez-Martínez L.

Enferm Infecc Microbiol Clin. 2018 Nov 5. pii: S0213-005X(18)30278-7. doi: 10.1016/j.eimc.2018.09.014. [Epub ahead of print] Review. English, Spanish.

PMID:
30409509
14.

Current use of daptomycin and systematic therapeutic drug monitoring: Clinical experience in a tertiary care institution.

Galar A, Muñoz P, Valerio M, Cercenado E, García-González X, Burillo A, Sánchez-Somolinos M, Juárez M, Verde E, Bouza E.

Int J Antimicrob Agents. 2019 Jan;53(1):40-48. doi: 10.1016/j.ijantimicag.2018.09.015. Epub 2018 Sep 19.

PMID:
30243587
15.

Identification of Nocardia species from clinical isolates using MALDI-TOF mass spectrometry.

Marín M, Ruiz A, Iglesias C, Quiroga L, Cercenado E, Martín-Rabadán P, Bouza E, Rodríguez-Sánchez B.

Clin Microbiol Infect. 2018 Dec;24(12):1342.e5-1342.e8. doi: 10.1016/j.cmi.2018.06.014. Epub 2018 Jun 20.

PMID:
29933050
16.

Can dalbavancin be used as a catheter lock solution?

Díaz-Ruíz C, Alonso B, Cercenado E, Cruces R, Bouza E, Muñoz P, Guembe M.

J Med Microbiol. 2018 May 17. doi: 10.1099/jmm.0.000749. [Epub ahead of print]

PMID:
29771236
17.

Antimicrobial susceptibility trends and evolution of isolates with extended spectrum β-lactamases among Gram-negative organisms recovered during the SMART study in Spain (2011-2015).

Cantón R, Loza E, Aznar J, Barrón-Adúriz R, Calvo J, Castillo FJ, Cercenado E, Cisterna R, González-Romo F, López-Hontangas JL, Suárez-Barrenechea AI, Tubau F, Molloy B, López-Mendoza D; SMART-Spain Working Group.

Rev Esp Quimioter. 2018 Apr;31(2):136-145. Epub 2018 Mar 12.

18.

Utility of rapid microbiological techniques for the diagnosis of severe infections.

Cercenado E.

Rev Esp Quimioter. 2017 Sep;30 Suppl 1:52-55. Review.

19.

Identification of Streptococcus pneumoniae lytA, plyA and psaA genes in pleural fluid by multiplex real-time PCR.

Sanz JC, Ríos E, Rodríguez-Avial I, Ramos B, Marín M, Cercenado E.

Enferm Infecc Microbiol Clin. 2018 Aug - Sep;36(7):428-430. doi: 10.1016/j.eimc.2017.07.007. Epub 2017 Aug 14. English, Spanish.

PMID:
28818481
20.

Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.

Aguado JM, Silva JT, Fernández-Ruiz M, Cordero E, Fortún J, Gudiol C, Martínez-Martínez L, Vidal E, Almenar L, Almirante B, Cantón R, Carratalá J, Caston JJ, Cercenado E, Cervera C, Cisneros JM, Crespo-Leiro MG, Cuervas-Mons V, Elizalde-Fernández J, Fariñas MC, Gavaldà J, Goyanes MJ, Gutiérrez-Gutiérrez B, Hernández D, Len O, López-Andujar R, López-Medrano F, Martín-Dávila P, Montejo M, Moreno A, Oliver A, Pascual A, Pérez-Nadales E, Román-Broto A, San-Juan R, Serón D, Solé-Jover A, Valerio M, Muñoz P, Torre-Cisneros J; Spanish Society of Transplantation (SET); Group for Study of Infection in Transplantation of the Spanish Society of Infectious Diseases and Clinical Microbiology (GESITRA-SEIMC); Spanish Network for Research in Infectious Diseases (REIPI) (RD16/0016).

Transplant Rev (Orlando). 2018 Jan;32(1):36-57. doi: 10.1016/j.trre.2017.07.001. Epub 2017 Jul 26. Review.

PMID:
28811074
21.

Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis.

Fortea JI, Zipprich A, Fernandez-Mena C, Puerto M, Bosoi CR, Almagro J, Hollenbach M, Bañares J, Rodríguez-Sánchez B, Cercenado E, Clément MA, Rose CF, Bañares R, Vaquero J, Ripoll C.

Liver Int. 2018 Jan;38(1):102-112. doi: 10.1111/liv.13510. Epub 2017 Sep 30.

PMID:
28665498
22.

Accurate Differentiation of Streptococcus pneumoniae from other Species within the Streptococcus mitis Group by Peak Analysis Using MALDI-TOF MS.

Marín M, Cercenado E, Sánchez-Carrillo C, Ruiz A, Gómez González Á, Rodríguez-Sánchez B, Bouza E.

Front Microbiol. 2017 Apr 25;8:698. doi: 10.3389/fmicb.2017.00698. eCollection 2017.

23.

Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain.

Càmara J, Marimón JM, Cercenado E, Larrosa N, Quesada MD, Fontanals D, Cubero M, Pérez-Trallero E, Fenoll A, Liñares J, Ardanuy C.

PLoS One. 2017 Apr 6;12(4):e0175224. doi: 10.1371/journal.pone.0175224. eCollection 2017.

24.

[Antimicrobial spectrum of dalbavancin. Mechanism of action and in vitro activity against Gram-positive microorganisms].

Cercenado E.

Enferm Infecc Microbiol Clin. 2017 Jan;35 Suppl 1:9-14. doi: 10.1016/S0213-005X(17)30029-0. Spanish.

PMID:
28129822
25.

Evaluation of the Xpert Carba-R (Cepheid) Assay Using Contrived Bronchial Specimens from Patients with Suspicion of Ventilator-Associated Pneumonia for the Detection of Prevalent Carbapenemases.

Burillo A, Marín M, Cercenado E, Ruiz-Carrascoso G, Pérez-Granda MJ, Oteo J, Bouza E.

PLoS One. 2016 Dec 16;11(12):e0168473. doi: 10.1371/journal.pone.0168473. eCollection 2016.

26.

[Epidemiology of the infection by resistant Gram-positive microorganisms].

Cercenado E.

Rev Esp Quimioter. 2016 Sep;29 Suppl 1:6-9. Review. Spanish.

27.

CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain.

Merino I, Shaw E, Horcajada JP, Cercenado E, Mirelis B, Pallarés MA, Gómez J, Xercavins M, Martínez-Martínez L, De Cueto M, Cantón R, Ruiz-Garbajosa P; ITUBRAS-GEIH-SEIMC Group.

J Antimicrob Chemother. 2016 Aug;71(8):2125-30. doi: 10.1093/jac/dkw133. Epub 2016 May 12.

PMID:
27494832
28.

Erratum for Marín et al., Clostridium difficile Isolates with High Linezolid MICs Harbor the Multiresistance Gene cfr.

Marín M, Martín A, Alcalá L, Cercenado E, Iglesias C, Reigadas E, Bouza E.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4428. doi: 10.1128/AAC.01066-16. Print 2016 Jul. No abstract available.

29.

Factors associated with severity in invasive community-acquired Staphylococcus aureus infections in children: a prospective European multicentre study.

Gijón M, Bellusci M, Petraitiene B, Noguera-Julian A, Zilinskaite V, Sanchez Moreno P, Saavedra-Lozano J, Glikman D, Daskalaki M, Kaiser-Labusch P, Falup-Pecurariu O, Montagnani C, Prieto L, Gené A, Trumpulyte G, Kulecnikova I, Lepe JA, Cercenado E, Kudinsky R, Makri A, Huppertz HI, Bleotu L, Cocchi P, García-Hierro P, Vitkauskiene A, Fortuny C, Zukovskaja V, Neth O, Santos M, Rokney A, Petra M, Lixandru R, Galli L, Guillén S, Chaves F, Rojo Conejo P.

Clin Microbiol Infect. 2016 Jul;22(7):643.e1-6. doi: 10.1016/j.cmi.2016.04.004. Epub 2016 Apr 21.

30.

[Methicillin-resistant Staphylococcus aureus carrying the mecC gene: an emerging problem?].

Vindel A, Cercenado E.

Enferm Infecc Microbiol Clin. 2016 May;34(5):277-9. doi: 10.1016/j.eimc.2016.01.010. Epub 2016 Feb 19. Spanish. No abstract available.

PMID:
26906690
31.

Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity.

Humanes B, Jado JC, Camaño S, López-Parra V, Torres AM, Álvarez-Sala LA, Cercenado E, Tejedor A, Lázaro A.

Biomed Res Int. 2015;2015:704382. doi: 10.1155/2015/704382. Epub 2015 Oct 4.

32.

[Laboratory detection of carbapenemase-producing Enterobacteriaceae].

Cercenado E.

Rev Esp Quimioter. 2015 Sep;28 Suppl 1:8-11. Review. Spanish.

33.

Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain.

Fernández-Martínez M, Miró E, Ortega A, Bou G, González-López JJ, Oliver A, Pascual A, Cercenado E, Oteo J, Martínez-Martínez L, Navarro F; Spanish Network for the Research in Infectious Diseases (REIPI).

Int J Antimicrob Agents. 2015 Aug;46(2):157-63. doi: 10.1016/j.ijantimicag.2015.03.008. Epub 2015 Apr 29.

PMID:
26022930
34.

Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC).

Gudiol F, Aguado JM, Almirante B, Bouza E, Cercenado E, Domínguez MÁ, Gasch O, Lora-Tamayo J, Miró JM, Palomar M, Pascual A, Pericas JM, Pujol M, Rodríguez-Baño J, Shaw E, Soriano A, Vallés J.

Enferm Infecc Microbiol Clin. 2015 Nov;33(9):625.e1-625.e23. doi: 10.1016/j.eimc.2015.03.015. Epub 2015 May 1.

PMID:
25937457
35.

Executive summary of the diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC).

Gudiol F, Aguado JM, Almirante B, Bouza E, Cercenado E, Domínguez MÁ, Gasch O, Lora-Tamayo J, Miró JM, Palomar M, Pascual A, Pericas JM, Pujol M, Rodríguez-Baño J, Shaw E, Soriano A, Vallés J.

Enferm Infecc Microbiol Clin. 2015 Nov;33(9):626-32. doi: 10.1016/j.eimc.2015.03.014. Epub 2015 Apr 30.

PMID:
25937456
36.

Clostridium difficile isolates with high linezolid MICs harbor the multiresistance gene cfr.

Marín M, Martín A, Alcalá L, Cercenado E, Iglesias C, Reigadas E, Bouza E.

Antimicrob Agents Chemother. 2015 Jan;59(1):586-9. doi: 10.1128/AAC.04082-14. Epub 2014 Nov 10. Erratum in: Antimicrob Agents Chemother. 2016 Jul;60(7):4428.

37.

Spread of Streptococcus pneumoniae serotype 8-ST63 multidrug-resistant recombinant Clone, Spain.

Ardanuy C, de la Campa AG, García E, Fenoll A, Calatayud L, Cercenado E, Pérez-Trallero E, Bouza E, Liñares J.

Emerg Infect Dis. 2014 Nov;20(11):1848-56. doi: 10.3201/eid2011.131215.

38.

Molecular epidemiology of community-associated methicillin-resistant Staphylococcus aureus in Spain: 2004-12.

Vindel A, Trincado P, Cuevas O, Ballesteros C, Bouza E, Cercenado E.

J Antimicrob Chemother. 2014 Nov;69(11):2913-9. doi: 10.1093/jac/dku232. Epub 2014 Jul 1.

PMID:
24990868
39.

Inhibitor-resistant TEM- and OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolates.

Oteo J, González-López JJ, Ortega A, Quintero-Zárate JN, Bou G, Cercenado E, Conejo MC, Martínez-Martínez L, Navarro F, Oliver A, Bartolomé RM, Campos J; Spanish Network for Research in Infectious Diseases (REIPI).

Antimicrob Agents Chemother. 2014 Jul;58(7):3874-81. doi: 10.1128/AAC.02738-13. Epub 2014 Apr 28.

40.

[Antimicrobial spectrum of ceftaroline. In vitro activity against methicillin-resistant staphylococci].

Cercenado E, Morosini MI.

Enferm Infecc Microbiol Clin. 2014 Mar;32 Suppl 2:8-14. doi: 10.1016/S0213-005X(14)70152-1. Spanish.

PMID:
24702973
41.

Improvement of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry identification of difficult-to-identify bacteria and its impact in the workflow of a clinical microbiology laboratory.

Rodríguez-Sánchez B, Marín M, Sánchez-Carrillo C, Cercenado E, Ruiz A, Rodríguez-Créixems M, Bouza E.

Diagn Microbiol Infect Dis. 2014 May;79(1):1-6. doi: 10.1016/j.diagmicrobio.2014.01.021. Epub 2014 Jan 30.

PMID:
24602850
42.

Gram-stain plus MALDI-TOF MS (Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry) for a rapid diagnosis of urinary tract infection.

Burillo A, Rodríguez-Sánchez B, Ramiro A, Cercenado E, Rodríguez-Créixems M, Bouza E.

PLoS One. 2014 Jan 22;9(1):e86915. doi: 10.1371/journal.pone.0086915. eCollection 2014.

43.

Rapid identification of linezolid resistance in Enterococcus spp. based on high-resolution melting analysis.

Alonso M, Marín M, Iglesias C, Cercenado E, Bouza E, García de Viedma D.

J Microbiol Methods. 2014 Mar;98:41-3. doi: 10.1016/j.mimet.2013.12.013. Epub 2013 Dec 28.

PMID:
24380715
44.

Recurrent pneumococcal invasive disease in the region of Madrid during a five-year period.

Sanz JC, Rodríguez-Avial I, Ríos E, Ramos B, Cercenado E.

Infection. 2014 Jun;42(3):475-83. doi: 10.1007/s15010-013-0571-3. Epub 2013 Dec 22.

PMID:
24363222
45.

Direct identification of pathogens from positive blood cultures using matrix-assisted laser desorption-ionization time-of-flight mass spectrometry.

Rodríguez-Sánchez B, Sánchez-Carrillo C, Ruiz A, Marín M, Cercenado E, Rodríguez-Créixems M, Bouza E.

Clin Microbiol Infect. 2014 Jul;20(7):O421-7. doi: 10.1111/1469-0691.12455. Epub 2013 Dec 24.

46.

Evaluation of new antimicrobials for the hospital formulary. Policies restricting antibiotic use in hospitals.

Pujol M, Delgado O, Puigventós F, Corzo JE, Cercenado E, Martínez JA.

Enferm Infecc Microbiol Clin. 2013 Sep;31 Suppl 4:45-50. doi: 10.1016/S0213-005X(13)70132-0.

PMID:
24129289
47.

Methicillin-resistant Staphylococcus aureus carrying the mecC gene: emergence in Spain and report of a fatal case of bacteraemia.

García-Garrote F, Cercenado E, Marín M, Bal M, Trincado P, Corredoira J, Ballesteros C, Pita J, Alonso P, Vindel A.

J Antimicrob Chemother. 2014 Jan;69(1):45-50. doi: 10.1093/jac/dkt327. Epub 2013 Aug 24.

PMID:
23975743
48.

Isolates of β-lactamase-negative ampicillin-resistant Haemophilus influenzae causing invasive infections in Spain remain susceptible to cefotaxime and imipenem.

García-Cobos S, Arroyo M, Pérez-Vázquez M, Aracil B, Lara N, Oteo J, Cercenado E, Campos J.

J Antimicrob Chemother. 2014 Jan;69(1):111-6. doi: 10.1093/jac/dkt324. Epub 2013 Aug 13.

PMID:
23943391
49.

Synthetic inhibitors of bacterial cell division targeting the GTP-binding site of FtsZ.

Ruiz-Avila LB, Huecas S, Artola M, Vergoñós A, Ramírez-Aportela E, Cercenado E, Barasoain I, Vázquez-Villa H, Martín-Fontecha M, Chacón P, López-Rodríguez ML, Andreu JM.

ACS Chem Biol. 2013 Sep 20;8(9):2072-83. doi: 10.1021/cb400208z. Epub 2013 Jul 31.

PMID:
23855511
50.

Pre-emptive broad-spectrum treatment for ventilator-associated pneumonia in high-risk patients.

Bouza E, Granda MJ, Hortal J, Barrio JM, Cercenado E, Muñoz P.

Intensive Care Med. 2013 Sep;39(9):1547-55. doi: 10.1007/s00134-013-2997-6. Epub 2013 Jun 28.

PMID:
23812339

Supplemental Content

Loading ...
Support Center